Consensus Abbott Laboratories Kazakhstan S.E.

Stocks

ABT_KZ

US0028241000

Medical Equipment, Supplies & Distribution

End-of-day quote Kazakhstan S.E. 18/09/2026			5-day change	1st Jan Change
105.00 ^USD	-3.67%		-4.55%	-27.08%

18/09	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI
17/09	Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026	CI

a33.YvQJnG3isBVSLZXPF-BcLcXKGuypvMR-QpXXmkiHNxM.J7xWyhix6lwdTvOZQoUvQamtaa7b0I0HA8rm0DriU1ojoDHXFYvDVAVgrQ~081abaf24566ba581df35f5ff9964a8f

Analysts' recommendations: Abbott Laboratories

21/08	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
13/08	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
28/07	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
28/07	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
23/07	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
22/07	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
17/07	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
17/07	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
17/07	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
17/07	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
17/07	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
17/07	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
17/07	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
17/07	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
06/07	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
01/07	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
12/06	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
27/05	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
05/05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
22/04	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…
22/04	Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113	MT
21/04	Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating	MT
21/04	Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating	MT
20/04	Argus Cuts Abbott Laboratories' Price Target to $125 From $140	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+17.2%
	MEDTRONIC PLC					+13.79%
	CENCORA, INC.					+19.6%
	BECTON, DICKINSON AND COMPANY					+8.14%
	HOYA CORPORATION					+33.6%
	DEXCOM, INC.					+5.74%
	MEDLINE INC.					+40.96%
	WEST PHARMACEUTICAL SERVICES, INC.					+11.89%
	SARTORIUS STEDIM BIOTECH					+18.88%
	Average					+18.87%
	Weighted average by Cap.					+17.66%